Mackenzie Financial Corp Charles River Laboratories International, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 971,268 shares of CRL stock, worth $181 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

971,268

Previous 929,160 4.53%

Holding current value

$181 Million

Previous $192 Million 0.32%

% of portfolio

0.29%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $7.91 Million - $10.3 Million	42,108 Added 4.53%	971,268 $191 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $544,250 - $708,641	-2,637 Reduced 0.28%	929,160 $192 Million
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $2.84 Million - $3.81 Million	13,939 Added 1.52%	931,797 $252 Million
Q4 2023 Jan 30, 2024	SELL	$164.52 - $238.84 $952,735 - $1.38 Million	-5,791 Reduced 0.63%	917,858 $217 Million
Q3 2023 Oct 25, 2023	BUY	$194.44 - $217.61 $876,341 - $980,768	4,507 Added 0.49%	923,649 $181 Million
Q2 2023 Aug 03, 2023	BUY	$183.71 - $210.25 $9.74 Million - $11.1 Million	53,032 Added 6.12%	919,142 $193 Million
Q1 2023 Apr 24, 2023	BUY	$191.89 - $259.92 $12.6 Million - $17 Million	65,534 Added 8.19%	866,110 $175 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $17.7 Million - $22.4 Million	89,751 Added 12.63%	800,576 $174 Million
Q3 2022 Oct 07, 2022	SELL	$182.44 - $250.54 $50.4 Million - $69.3 Million	-276,409 Reduced 28.0%	710,825 $140 Million
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $26.7 Million - $39.6 Million	131,020 Added 15.3%	987,234 $211 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $141 Million - $200 Million	553,121 Added 182.49%	856,214 $243 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $1.34 Million - $1.71 Million	-3,820 Reduced 1.24%	303,093 $114 Million
Q3 2021 Nov 08, 2021	SELL	$372.64 - $458.3 $52.4 Million - $64.4 Million	-140,543 Reduced 31.41%	306,913 $127 Million
Q2 2021 Aug 11, 2021	BUY	$294.17 - $371.65 $54.6 Million - $69 Million	185,667 Added 70.92%	447,456 $166 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $41.8 Million - $50.2 Million	-167,554 Reduced 39.03%	261,789 $75.9 Million
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $13.5 Million - $15.4 Million	60,774 Added 16.49%	429,343 $107 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $502,628 - $648,326	2,863 Added 0.78%	368,569 $83.5 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $12.4 Million - $19.8 Million	104,445 Added 39.98%	365,706 $63.8 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $660,948 - $1.19 Million	6,683 Added 2.63%	261,261 $33 Million
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $8.75 Million - $10.6 Million	69,400 Added 37.48%	254,578 $38.9 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $22.9 Million - $26.3 Million	183,382 Added 10210.58%	185,178 $24.5 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $3.38 Million - $4.07 Million	-27,388 Reduced 93.85%	1,796 $255,000
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $3.06 Million - $4.28 Million	29,184 New	29,184 $4.24 Million
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $73.7 Million - $84.4 Million	-719,731 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $34.5 Million - $40.5 Million	-351,447 Reduced 32.81%	719,731 $76.8 Million
Q4 2017 Feb 13, 2018	BUY	$100.43 - $118.09 $14.3 Million - $16.8 Million	142,382 Added 15.33%	1,071,178 $117 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $40.4 Million - $45.6 Million	417,739 Added 81.74%	928,796 $100 Million
Q2 2017 Aug 14, 2017	BUY	N/A	511,057	511,057 $51.7 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.47B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Charles River Laboratories International, Inc. Transaction History